High-content Screening System
The cutting-edge TissueFAXS PLUS high-content screening system by TissueGnostics is engineered for advanced multi-channel fluorescence microscopy and exceptional high-resolution imaging
Read moreThe cutting-edge TissueFAXS PLUS high-content screening system by TissueGnostics is engineered for advanced multi-channel fluorescence microscopy and exceptional high-resolution imaging
Read morePfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read moreBoehringer Ingelheim and Enara Bio reported that they have entered into a strategic partnership and licensing agreement to study and
Read moreUtilising Surface Plasmon Resonance (SPR) analysis for drug development or drug discovery can make a big impact. SPR analysis can
Read morePhenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6
Read moreViiV Healthcare’s GEMINI studies showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine, appeared to have non-inferior potency in
Read moreBristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion
Read moreHarbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Read moreScientists at clinical-stage biopharmaceutical company Harbour BioMed (HBM), Utrecht University and Erasmus Medical Center announced that they have discovered a
Read moreSwiss pharma giant Roche has received Emergency Use Authorisation (EUA) from the FDA for its latest COVID-19 antibody test –
Read more